Author:
Wilhelm Imola,Molnár Kinga,Krizbai István A.
Publisher
Springer International Publishing
Reference131 articles.
1. Dias, K., et al., Claudin-Low Breast Cancer; Clinical & Pathological Characteristics. PLoS One, 2017. 12(1): p. e0168669.
2. Harrell, J.C., et al., Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res Treat, 2012. 132(2): p. 523-35.
3. Izraely, S., et al., The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis. Int J Cancer, 2015. 136(6): p. 1296-307.
4. Figueira, I., et al., Picturing Breast Cancer Brain Metastasis Development to Unravel Molecular Players and Cellular Crosstalk. Cancers (Basel), 2021. 13(4).
5. Nag S., B.D.J., Blood–brain barrier, exchange of metabolites and gases, in Pathology and Genetics: Cerebrovascular Diseases. , H. Kalimo, Editor. 2005, Basel: ISN Neuropath Press. p. p. 22 - 29.